LncRNAs in vascular biology and disease

V Simion, S Haemmig, MW Feinberg - Vascular pharmacology, 2019 - Elsevier
Accumulating studies indicate that long non-coding RNAs (lncRNAs) play important roles in
the regulation of diverse biological processes involved in homeostatic control of the vessel …

Exosome-cargoed microRNAs: Potential therapeutic molecules for diabetic wound healing

R Lou, J Chen, F Zhou, C Wang, CH Leung, L Lin - Drug Discovery Today, 2022 - Elsevier
Highlights•Exosomal microRNAs are pivotal regulators of angiogenesis during wound
healing.•Exosomal microRNAs regulate VEGF expression and downstream signaling …

Cerium oxide nanoparticle conjugation to microRNA-146a mechanism of correction for impaired diabetic wound healing

LC Dewberry, SM Niemiec, SA Hilton… - … , Biology and Medicine, 2022 - Elsevier
Diabetic wounds represent a significant healthcare burden and are characterized by
impaired wound healing due to increased oxidative stress and persistent inflammation. We …

A glimpse of the mechanisms related to renal fibrosis in diabetic nephropathy

LF Zeng, Y Xiao, L Sun - Renal Fibrosis: Mechanisms and Therapies, 2019 - Springer
Diabetic nephropathy (DN) is a common kidney disease in people with diabetes, which is
also a serious microvascular complication of diabetes and the main cause of end-stage …

Long noncoding RNA CA7-4 promotes autophagy and apoptosis via sponging MIR877-3P and MIR5680 in high glucose-induced vascular endothelial cells

X Zhao, L Su, X He, B Zhao, J Miao - Autophagy, 2020 - Taylor & Francis
Vascular endothelial cells (VECs) that form the inner wall of blood vessels can be injured by
high glucose-induced autophagy and apoptosis. Although the role of long noncoding RNA …

A synthetic microRNA‐92a inhibitor (MRG‐110) accelerates angiogenesis and wound healing in diabetic and nondiabetic wounds

CL Gallant‐Behm, J Piper, BA Dickinson… - Wound repair and …, 2018 - Wiley Online Library
There is a strong unmet need for new therapeutics to accelerate wound healing across both
chronic and acute indications. It is well established that local tissue hypoxia, vascular …

[HTML][HTML] Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options

T Salvatore, R Galiero, A Caturano, E Vetrano… - Biomedicines, 2022 - mdpi.com
Diabetic patients are frequently affected by coronary microvascular dysfunction (CMD), a
condition consisting of a combination of altered vasomotion and long-term structural change …

Endothelial dysfunction in diabetes and hypertension: role of microRNAs and long non-coding RNAs

H Zhang, Q Xu, A Thakur, MO Alfred, M Chakraborty… - Life sciences, 2018 - Elsevier
The vascular endothelium acts as a barrier between the blood flow and the inner lining of
the vessel wall, and it functions as a filtering machinery to filter out any unwanted transfer of …

[HTML][HTML] Long non-coding RNA NEAT1 regulates pyroptosis in diabetic nephropathy via mediating the miR-34c/NLRP3 axis

JF Zhan, HW Huang, C Huang, LL Hu… - Kidney and Blood …, 2020 - karger.com
Introduction: Diabetic nephropathy (DN) is a serious complication of diabetes mellitus and is
considered to be a sterile inflammatory disease. Increasing evidence suggest that pyroptosis …

MicroRNA-615-5p regulates angiogenesis and tissue repair by targeting AKT/eNOS (protein kinase B/endothelial nitric oxide synthase) signaling in endothelial cells

B Icli, W Wu, D Ozdemir, H Li, HS Cheng… - … and Vascular Biology, 2019 - Am Heart Assoc
Objective—In response to tissue injury, the appropriate progression of events in
angiogenesis is controlled by a careful balance between pro and antiangiogenic factors. We …